Stay updated on Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.

Latest updates to the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page
- ChecktodayChange DetectedThe Record History page adds a new revision entry v3.3.4 and removes the previous v3.3.3 entry. This is a log update and does not affect trial data or functionality.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedNew Revision: v3.3.3 appears on the page and the HHS Vulnerability Disclosure link is removed, indicating minor UI and footer updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check50 days agoChange DetectedThe record history now includes a new revision v3.3.2 and removes v3.2.0, reflecting a routine update to the study's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRemoved the government funding lapse notice from the page; this informational banner did not relate to the trial data or core content.SummaryDifference0.8%

- Check71 days agoChange DetectedA new version entry on 2024-03-27 was added to the study record history, noting updates to recruitment status and other study details; to avoid alerts for small changes, set an alert condition.SummaryDifference0.1%

- Check100 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removed mention of v3.1.0.SummaryDifference13%

Stay in the know with updates to Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.